|Page (1) of 1 - 08/02/11||email article||print page|
Drugmaker Pfizer's 2Q net rises 5 pct. on lower restructuring charges, taxes; sales dip 1 pct.
NEW YORK (AP) ' Pfizer Inc. says it second-quarter profit is up 5 percent despite slightly lower sales, thanks to lower taxes and reduced restructuring charges from its 2009 purchase of Wyeth.
The world's biggest drugmaker says its net income was $2.61 billion, or 33 cents per share, up from $2.48 billion, or 31 cents a share, in 2010's second quarter.
Excluding one-time items, the New York-based maker of cholesterol fighter Lipitor and impotence pill Viagra would have made $4.73 billion, or 60 cents a share.
Analysts surveyed by FactSet were expecting earnings per share of 59 cents.
Pfizer says its revenue totaled $16.98 billion, down 1 percent despite strong growth in emerging markets. Analysts were looking for revenue of $17.02 billion.